Brokerages Expect LifePoint Health Inc (LPNT) to Announce $0.81 Earnings Per Share

Wall Street analysts expect LifePoint Health Inc (NASDAQ:LPNT) to report earnings per share (EPS) of $0.81 for the current fiscal quarter, Zacks reports. Eight analysts have provided estimates for LifePoint Health’s earnings, with the lowest EPS estimate coming in at $0.75 and the highest estimate coming in at $0.91. LifePoint Health posted earnings per share of $1.09 in the same quarter last year, which would indicate a negative year over year growth rate of 25.7%. The company is scheduled to report its next quarterly earnings results before the market opens on Friday, February 23rd.

According to Zacks, analysts expect that LifePoint Health will report full year earnings of $3.64 per share for the current year, with EPS estimates ranging from $3.56 to $3.75. For the next fiscal year, analysts anticipate that the firm will report earnings of $4.14 per share, with EPS estimates ranging from $3.53 to $4.96. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research analysts that follow LifePoint Health.

A number of brokerages have weighed in on LPNT. BidaskClub raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a research note on Thursday, January 11th. William Blair reaffirmed an “outperform” rating on shares of LifePoint Health in a research note on Tuesday, November 21st. Credit Suisse Group assumed coverage on shares of LifePoint Health in a research note on Thursday, November 2nd. They issued a “neutral” rating and a $54.00 price target on the stock. Robert W. Baird set a $55.00 price objective on shares of LifePoint Health and gave the stock a “buy” rating in a research report on Monday, October 30th. Finally, Raymond James Financial reissued a “market perform” rating on shares of LifePoint Health in a research report on Monday, October 30th. One analyst has rated the stock with a sell rating, fourteen have issued a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $58.67.

In other LifePoint Health news, Director Marguerite Kondracke sold 3,907 shares of the company’s stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $44.73, for a total value of $174,760.11. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider David M. Dill sold 45,000 shares of the company’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the completion of the transaction, the insider now owns 252,673 shares in the company, valued at $12,259,693.96. The disclosure for this sale can be found here. 8.76% of the stock is currently owned by insiders.

Large investors have recently added to or reduced their stakes in the business. Bank of New York Mellon Corp increased its holdings in shares of LifePoint Health by 28.7% in the third quarter. Bank of New York Mellon Corp now owns 795,233 shares of the company’s stock valued at $46,044,000 after purchasing an additional 177,329 shares during the last quarter. Convergence Investment Partners LLC acquired a new position in shares of LifePoint Health in the third quarter valued at $811,000. Stevens Capital Management LP acquired a new position in shares of LifePoint Health in the third quarter valued at $1,395,000. New York State Common Retirement Fund increased its holdings in shares of LifePoint Health by 3.2% in the third quarter. New York State Common Retirement Fund now owns 84,969 shares of the company’s stock valued at $4,920,000 after purchasing an additional 2,669 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of LifePoint Health by 26.4% in the third quarter. JPMorgan Chase & Co. now owns 132,589 shares of the company’s stock valued at $7,757,000 after purchasing an additional 27,726 shares during the last quarter.

Shares of LifePoint Health (NASDAQ:LPNT) traded up $0.60 on Thursday, reaching $49.70. 601,053 shares of the company’s stock were exchanged, compared to its average volume of 502,365. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.65 and a current ratio of 1.85. LifePoint Health has a 1 year low of $42.50 and a 1 year high of $67.95. The company has a market capitalization of $1,940.00, a price-to-earnings ratio of 11.78, a P/E/G ratio of 1.12 and a beta of 0.52.

LifePoint Health declared that its Board of Directors has authorized a share buyback program on Friday, October 27th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.

COPYRIGHT VIOLATION WARNING: This story was published by Week Herald and is the property of of Week Herald. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at https://weekherald.com/2018/02/22/brokerages-expect-lifepoint-health-inc-lpnt-to-announce-0-81-earnings-per-share.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply